NCT07444814
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07444814
Title Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Whitehawk Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas NOT_YET_RECRUITING Little Rock Arkansas 72205-7199 United States Details
UCLA - Hematology/Oncology Clinical Research Unit NOT_YET_RECRUITING Los Angeles California 90095 United States Details
St. Francis Medical Center (OSF Healthcare) NOT_YET_RECRUITING Peoria Illinois 61637 United States Details
START - Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Hackensack University Medical Center - John Theurer Cancer Center NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Care Center NOT_YET_RECRUITING Buffalo New York 14263 United States Details
University Hospital - Cleveland Medical Center NOT_YET_RECRUITING Cleveland Ohio 44106 United States Details
NEXT Oncology - Austin RECRUITING Austin Texas 78758 United States Details
NEXT - Oncology - Houston RECRUITING Houston Texas 77054 United States Details
START - San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology - Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center NOT_YET_RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field